- Beat earnings estimates in all of the last 4 quarters
- Excellent financial health (Piotroski 8/9)
- Healthy interest coverage ratio of 28.8x
Weaker technical forecast for ASTELLAS PHARMA INC as stock downgraded to Sell Candidate
(Updated on Jun 23, 2026)
The ASTELLAS PHARMA INC stock price fell by -2.30% on the last day (Tuesday, 23rd Jun 2026) from $13.47 to $13.16. During the last trading day the stock fluctuated 1.00% from a day low at $13.04 to a day high of $13.17. The price has fallen in 6 of the last 10 days and is down by -2.45% for this period. Volume has increased on the last day by 10 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 23 thousand shares were bought and sold for approximately $304.19 thousand.
The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $13.40 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.43% during the next 3 months and, with a 90% probability hold a price between $9.36 and $10.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ALPMY Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ASTELLAS PHARMA INC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.36 and $13.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 13, 2026, and so far it has fallen -12.21%. Further fall is indicated until a new bottom pivot has been found. ASTELLAS PHARMA INC gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for ASTELLAS PHARMA INC stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.130 (1.00%) between high and low. For the last week, the stock has had daily average volatility of 1.32%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ALPMY) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect ASTELLAS PHARMA INC to open at $13.12, and during the day (based on 14 day Average True Range), to move between $13.00 and $13.32, which gives a possible trading interval of +/-$0.321 (+/-2.47%) up or down from last closing price. If ASTELLAS PHARMA INC takes out the full calculated possible swing range there will be an estimated 2.47% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $13.30, some $0.140 (1.06%) from the current price of $13.16, our system finds the risk reward not very attractive.
Is ASTELLAS PHARMA INC stock A Buy?
ASTELLAS PHARMA INC holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.970
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $13.12 ( 0.279%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ALPMY Performance
Trading levels for ALPMY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.25 | 0.709% |
| R2 | 13.20 | 0.332% |
| R1 | 13.17 | 0.0987% |
| Price | 13.16 | |
| S1 | 13.07 | -0.656% |
| S2 | 13.04 | -0.89% |
| S3 | 12.99 | -1.27% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 16.09 | 22.26% |
| R2 | 16.02 | 21.73% |
| R1 | 13.30 | 1.06% |
| Price | 13.16 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
ALPMY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 31, 2026 | Mar 31, 2026 | Mar 31, 2026 | $0.214 | 1.32% |
| 2 | Mar 30, 2026 | Mar 30, 2026 | Jun 03, 2026 | $0.244 | 1.48% |
| 3 | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | $0.226 | 2.08% |
| 4 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | $0.214 | 2.22% |
| 5 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | $0.227 | 1.98% |
FAQ
Click here for our free guide on how to buy ASTELLAS PHARMA INC Stock.
Buy ALPMY